What Does Ephedrine Do? Uses, Effects, and Risks

Ephedrine is a stimulant that activates the sympathetic nervous system, raising blood pressure, opening airways, and increasing heart rate and metabolic activity. Derived originally from plants in the Ephedra genus, it has been used medically for decades to treat low blood pressure during surgery and, historically, as a bronchodilator for asthma. But ephedrine’s stimulant properties also made it wildly popular in over-the-counter weight-loss and energy supplements through the 1990s, a period that ended with thousands of adverse event reports and an eventual FDA ban on ephedra-containing dietary supplements. The drug remains in clinical use today under tightly controlled circumstances, and understanding what it actually does in the body helps explain both why it works and why it can be dangerous.

How Ephedrine Works in the Body

Ephedrine is a sympathomimetic amine, meaning it mimics and amplifies the effects of your body’s “fight or flight” chemicals, particularly norepinephrine. It does this in two ways. First, it directly stimulates adrenergic receptors on the surfaces of cells in the heart, blood vessels, lungs, and elsewhere. Second, and perhaps more importantly, it triggers the release of stored norepinephrine from nerve endings, flooding the synapse with additional stimulatory signals. This dual action is what gives ephedrine its broad range of effects: constricted blood vessels, a faster and harder-pumping heart, relaxed bronchial smooth muscle, and heightened metabolic rate.

That indirect mechanism also explains one of ephedrine’s quirks. With repeated dosing, the nerve endings can become depleted of their norepinephrine stores, which means subsequent doses produce a weaker response. This phenomenon, sometimes called tachyphylaxis, is well documented with sympathomimetic agents and occurs because the drug depends on a finite reservoir of signaling molecules inside the nerve terminal.¹ It is an important clinical consideration: a dose that works well the first time may not work as well the fifth time in a short span.

Ephedrine and pseudoephedrine are closely related molecules, sharing the same atoms arranged slightly differently. Despite being near-identical chemically, their biological effects diverge. Pseudoephedrine is a weaker cardiovascular stimulant and a more selective nasal decongestant, which is why it ended up in cold medicines while ephedrine found a broader pharmacological role.²

Medical Uses During Surgery and Anesthesia

The most common clinical use of ephedrine today is inside operating rooms and labor-and-delivery suites. When general or spinal anesthesia causes a patient’s blood pressure to drop, ephedrine is one of the go-to drugs for bringing it back up quickly. A prospective study in middle-aged and older patients found that ephedrine significantly increased both mean arterial pressure and cardiac output across all groups studied.³ Unlike some other vasopressors that only squeeze blood vessels tighter, ephedrine also boosts how much blood the heart pumps per minute, which makes it useful when the goal is to restore overall circulation rather than just inflate a number on a monitor.

During cesarean deliveries under spinal anesthesia, ephedrine has been a traditional first choice for treating the blood pressure drop that affects a large share of patients. Research comparing ephedrine with norepinephrine in that setting found both drugs comparably effective at preventing hypotension, though the two have different side-effect profiles.⁴ One concern specific to obstetrics is that ephedrine crosses the placenta far more readily than alternatives like phenylephrine. A study measuring drug levels in umbilical cord blood found that ephedrine’s placental transfer ratio was dramatically higher, and the babies in the ephedrine group showed signs of greater metabolic stress, including lower blood pH and higher lactate levels.⁵ This finding has shifted many anesthesiologists toward phenylephrine as a first-line agent during cesarean sections, reserving ephedrine for situations where the mother’s heart rate is already low.

Bronchodilation and the Asthma Connection

Before modern inhalers became standard, ephedrine was one of the few drugs available for opening constricted airways in people with asthma. It relaxes the smooth muscle that lines bronchial tubes, making it easier to breathe. An older clinical study in asthmatic patients showed that a single oral dose of ephedrine produced measurable bronchodilation, and interestingly, two weeks of regular low-dose use did not cause the drug to lose its airway-opening effect or lead to deterioration in lung function.⁶ That said, modern beta-agonist inhalers deliver the same type of airway relief with far fewer cardiovascular side effects. Ephedrine is no longer a first-line asthma treatment in most of the world, but it still appears in some older combination formulas.

Metabolic Effects and Weight Loss

Ephedrine’s stimulant properties extend to metabolism. By activating beta-adrenergic receptors, it ramps up the rate at which your body burns calories, even at rest. Research measuring overnight energy expenditure found that a single dose of ephedrine raised metabolic rate by about 3% above baseline, and chronic treatment over several days raised it by roughly 5%, with the increase linked specifically to greater fat oxidation.⁷ A 5% bump in resting energy expenditure sounds modest, but over weeks and months it can contribute meaningfully to a caloric deficit.

The effect is more pronounced when ephedrine is combined with caffeine. A double-blind trial in obese patients on an energy-restricted diet found that the ephedrine-caffeine combination produced significantly greater weight loss than placebo over 24 weeks, while ephedrine alone and caffeine alone were no better than placebo.⁸ The synergy between the two compounds has been well recognized. Caffeine blocks an enzyme that breaks down the chemical messenger ephedrine relies on, effectively prolonging and amplifying its stimulant action.⁹

One wrinkle worth knowing: ephedrine’s ability to activate brown adipose tissue, the calorie-burning fat that generates heat, appears to depend on body composition. Imaging studies found that ephedrine activated brown fat in lean participants but not in obese ones.¹⁰ The reasons are not fully understood, but it suggests that the metabolic benefits of ephedrine may be blunted in the very population most likely to seek it out for weight loss.

Effects on Athletic Performance

Ephedrine’s stimulant properties made it a popular ingredient in sports supplements before tighter regulations arrived. The actual evidence for performance enhancement is mixed but not entirely dismissive. In a controlled study of trained runners, ephedrine shaved about a minute off 10-kilometer run times compared with placebo, with the improvement concentrated in the second half of the run, suggesting it helped runners maintain pace as fatigue set in.¹¹ In resistance exercise, ephedrine increased the number of repetitions completed during the first set of both leg-press and bench-press exercises, resulting in more total weight lifted across the session.¹²

Interestingly, both studies attributed the performance gains primarily to ephedrine itself rather than to the caffeine-ephedrine combination, finding no additive benefit from caffeine on top of ephedrine in the exercise context. That contrasts with the weight-loss data, where the combination clearly outperformed either drug alone. A broader review of the literature, however, concluded that most scientific data do not support the ergogenic claims that supplement manufacturers were making, and that the risks of adverse effects outweigh any marginal performance benefit.¹³

Cardiovascular Risks

This is where ephedrine’s story turns serious. The same sympathetic activation that raises blood pressure during surgery can, in unsupervised settings, push the cardiovascular system past safe limits. A landmark review of adverse event reports submitted to the FDA found that among events deemed related to ephedra-containing supplements, nearly half involved cardiovascular symptoms. Hypertension was the most frequently reported problem, followed by palpitations and rapid heart rate, stroke, and seizures. Ten of those events resulted in death, and 13 produced permanent disability.¹⁴

The combination of ephedrine with caffeine appears to amplify cardiovascular danger. Animal research showed dramatic age-dependent toxicity: among older rats given a high dose of ephedrine plus caffeine, more than half died within hours, with tissue examination revealing bleeding and muscle-cell death in the heart. Younger rats given the same doses all survived.¹⁵ Animal doses do not translate directly to human scenarios, but the finding reinforced concerns that older users with pre-existing cardiovascular changes were at heightened risk.

Psychiatric and Neurological Side Effects

The cardiovascular dangers have historically received the most attention, but ephedrine can also destabilize the brain. An analysis of FDA adverse event reports specifically focused on psychiatric effects found a disturbing range of outcomes. The most commonly reported events included psychosis, severe depression, mania or agitation, hallucinations, sleep disturbance, and suicidal thoughts. Ten cases involved physical harm to self or others, five led to criminal charges, and at least 26 required hospitalization, some of it involuntary.¹⁶

These psychiatric effects can also appear as part of a broader sympathomimetic toxidrome in overdose situations. The clinical picture of sympathomimetic poisoning, which applies to ephedrine along with amphetamines, cocaine, and other stimulants, includes delirium, paranoia, seizures, elevated body temperature, dilated pupils, rapid heart rate, and dangerously high blood pressure.¹⁷ In emergency settings, management focuses on controlling agitation, lowering temperature, and protecting the heart.

Drug Interactions That Multiply the Danger

Ephedrine’s reliance on norepinephrine release means that anything else in the body affecting norepinephrine levels can dramatically change how the drug behaves. The most dangerous class of interaction involves monoamine oxidase inhibitors (MAOIs), a category of antidepressants and anti-Parkinson’s drugs. MAOIs block the enzyme that normally breaks down norepinephrine, so when ephedrine triggers a flood of it, the body cannot clear it efficiently. The result can be a sudden, extreme spike in blood pressure.

Even newer, more selective MAOIs are not entirely safe to combine with ephedrine. A study in healthy volunteers found that moclobemide, a reversible MAO inhibitor considered milder than older drugs in the class, roughly tripled ephedrine’s effect on systolic blood pressure and nearly quadrupled its effect on diastolic blood pressure. The incidence of palpitations and headache also rose substantially.¹⁸ Anyone taking an MAOI, or who has taken one within the past two weeks, should not use ephedrine in any form.

The Plant Behind the Drug

Ephedrine is not a purely synthetic invention. It was first isolated from Ephedra sinica, a shrubby plant known in traditional Chinese medicine as ma huang and used for respiratory complaints for centuries. Multiple species within the Ephedra genus produce ephedrine and the related compound pseudoephedrine, though the concentrations vary substantially. Chemical analysis of various Ephedra species found that total ephedrine and pseudoephedrine content ranged from about 21 to 35 milligrams per gram of dry plant weight, depending on the species.¹⁹ That variability is one reason crude herbal preparations were inherently risky: a user could not know how much active drug they were getting from batch to batch.

Ephedrine and Anti-Doping Rules

Ephedrine is classified as a prohibited substance by the World Anti-Doping Agency above a specific urinary concentration threshold. This creates a practical problem for athletes who might take a cold medicine containing a related compound. Research tracking drug elimination in urine after standard therapeutic doses of decongestant preparations found that levels could remain above doping-control cut-off concentrations for a minimum of six hours after the last dose of certain formulations, and over 16 hours for pseudoephedrine.²⁰ A separate study found that even a single 25-milligram dose of ephedrine could push urine concentrations above the threshold if a sample were collected within about eight hours.²¹

The practical upshot: if you are a competitive athlete subject to drug testing, even legitimate use of an over-the-counter cold product containing ephedrine or pseudoephedrine can trigger a positive test. Most sports medicine guidelines recommend switching to a non-stimulant decongestant or allowing ample washout time before competition.

Why Ephedrine Is Tightly Regulated

Beyond its direct health risks, ephedrine became entangled in the methamphetamine crisis. The chemical structure of ephedrine is one straightforward reduction reaction away from methamphetamine, and clandestine labs routinely extracted it from over-the-counter cold and allergy products as a precursor.²² That diversion prompted a layered regulatory response. In the United States, the Combat Methamphetamine Epidemic Act of 2005 moved products containing ephedrine and pseudoephedrine behind the pharmacy counter, limited purchase quantities, and required identification and signature at the point of sale. Some states went further: Oregon and Mississippi reclassified these products as prescription-only, and clandestine lab seizures dropped sharply afterward.²² Forensic scientists have even developed isotope-ratio analysis methods to trace seized methamphetamine back to specific batches of ephedrine precursor.²³

For ephedra-containing dietary supplements specifically, the FDA issued a final rule banning their sale in 2004 after concluding that the products posed an unreasonable risk of illness or injury. That ban remains in effect. Pharmaceutical-grade ephedrine, however, is still manufactured and used in hospitals. The distinction matters: the ban targeted the unregulated supplement market, where doses were uncontrolled and consumers had no medical oversight, not the clinical drug itself.

Who Should Never Take Ephedrine

Given the range of effects described above, certain groups face outsized risk. People with high blood pressure, heart disease, arrhythmias, or a history of stroke should avoid ephedrine entirely. The same applies to anyone with hyperthyroidism, since the thyroid and sympathetic nervous system amplify each other, and to people with anxiety disorders or a history of psychosis, given the psychiatric adverse events documented in FDA reports. The obstetric data showing high placental transfer and fetal metabolic stress mean that ephedrine’s use in pregnant patients is increasingly reserved for specific anesthetic scenarios under direct physician supervision.⁵ And the interaction with MAO inhibitors is dangerous enough that the combination should be treated as a hard contraindication, not a caution.¹⁸

Older adults face compounded risk as well. Age-related cardiovascular changes reduce the margin of safety, a pattern consistent with the animal data showing sharply higher mortality in older rats exposed to high-dose ephedrine and caffeine.¹⁵ If you are over 60 and encounter a product containing ephedrine, whether sold legally in another country or obtained online, the risk-to-benefit math looks especially unfavorable outside a hospital setting.